A detailed history of Black Rock Inc. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Black Rock Inc. holds 21,753,007 shares of LAB stock, worth $44.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,753,007
Previous 5,450,229 299.12%
Holding current value
$44.4 Million
Previous $14.8 Million 160.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.65 - $2.92 $26.9 Million - $47.6 Million
16,302,778 Added 299.12%
21,753,007 $38.5 Million
Q1 2024

May 10, 2024

BUY
$1.87 - $2.78 $7.18 Million - $10.7 Million
3,840,621 Added 238.61%
5,450,229 $14.8 Million
Q4 2023

Feb 13, 2024

BUY
$1.59 - $2.73 $388,316 - $666,731
244,224 Added 17.89%
1,609,608 $3.56 Million
Q3 2023

Nov 13, 2023

SELL
$1.9 - $3.05 $136,914 - $219,783
-72,060 Reduced 5.01%
1,365,384 $3.96 Million
Q2 2023

Aug 11, 2023

BUY
$1.47 - $2.56 $26,886 - $46,822
18,290 Added 1.29%
1,437,444 $2.77 Million
Q1 2023

May 12, 2023

BUY
$1.3 - $2.24 $15,317 - $26,393
11,783 Added 0.84%
1,419,154 $2.77 Million
Q4 2022

Feb 13, 2023

SELL
$0.93 - $1.52 $537,626 - $878,701
-578,093 Reduced 29.12%
1,407,371 $1.65 Million
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $34,920 - $65,396
-31,746 Reduced 1.57%
1,985,464 $2.18 Million
Q2 2022

Aug 12, 2022

SELL
$1.6 - $3.99 $6.64 Million - $16.6 Million
-4,148,506 Reduced 67.28%
2,017,210 $3.23 Million
Q1 2022

May 12, 2022

SELL
$2.8 - $3.96 $239,439 - $338,635
-85,514 Reduced 1.37%
6,165,716 $22.1 Million
Q4 2021

Feb 10, 2022

SELL
$3.63 - $6.13 $361,181 - $609,928
-99,499 Reduced 1.57%
6,251,230 $24.5 Million
Q3 2021

Nov 09, 2021

SELL
$5.5 - $7.41 $72,638 - $97,863
-13,207 Reduced 0.21%
6,350,729 $41.9 Million
Q2 2021

Aug 11, 2021

BUY
$4.35 - $6.35 $27.7 Million - $40.4 Million
6,363,936 New
6,363,936 $39.2 Million

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $160M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.